Private Wealth Management Group, LLC Xilio Therapeutics, Inc. Transaction History
Private Wealth Management Group, LLC
- $253 Billion
- Q3 2024
A detailed history of Private Wealth Management Group, LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 310 shares of XLO stock, worth $350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
310Holding current value
$350% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
34Shares Held
14MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$5.16 Million0.65% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3MShares$3.39 Million0.08% of portfolio
-
Morgan Stanley New York, NY1.52MShares$1.72 Million0.0% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.63 Million16.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$1.02 Million0.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $31M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...